Dr-Gabriel-N-Hortobagyi

Gabriel N. Hortobagyi, MD, FACP Professor of Medicine, Department of Breast Medical Oncology, Division of Cancer Medicine, UTMDACC, Nellie B. Connally Chair in Breast Cancer, Department of Breast Medical Oncology, Division of Cancer Medicine Program Director, Department of Breast Medical Oncology Susan G. Komen Interdisciplinary Breast Fellowship Program The University of Texas MD Anderson Cancer Center Houston, TX

Dr. Hortobagyi

RSS
Facebook
Facebook
Google+
https://medicalresearch.com/cancer-_-oncology/breast-cancer/one-year-follow-up-of-kisqali-ribociclib-plus-petrozole-in-hr-her2-advanced-breast-cancer-demonstrates-continued-efficacy/35302/attachment/dr-gabriel-n-hortobagyi-2/

Gabriel N. Hortobagyi, MD, FACP
Professor of Medicine, Department of Breast Medical Oncology,
Division of Cancer Medicine, UTMDACC,
Nellie B. Connally Chair in Breast Cancer, Department of Breast Medical Oncology, Division of Cancer Medicine
Program Director, Department of Breast Medical Oncology
Susan G. Komen Interdisciplinary Breast Fellowship Program
The University of Texas MD Anderson Cancer Center
Houston, TX

RSS
Facebook
Facebook
Google+
https://medicalresearch.com/cancer-_-oncology/breast-cancer/one-year-follow-up-of-kisqali-ribociclib-plus-petrozole-in-hr-her2-advanced-breast-cancer-demonstrates-continued-efficacy/35302/attachment/dr-gabriel-n-hortobagyi-2/

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.